Cigna Keeps Medical Costs in Check in 3Q, Raises Full-Year Earnings Outlook
-
Nov 04, 2022
Cigna Corp. on Nov. 3 reported third-quarter adjusted earnings per share (EPS) of $6.04, beating the Wall Street consensus expectation of $5.72 and getting a nod from one equities analyst for delivering âwell-controlled medical costs.â During the companyâs conference call to discuss quarterly results, executives touted Cignaâs big PBM contract win that will allow it to provide pharmacy benefits for Centene Corp. Yet they also fielded a critical analyst question about whether Cignaâs mergers and acquisitions (M&A) strategy is keeping up with the competition.Â
On the subject of the Centene PBM contract, which will begin in 2024 and cover 20 million members, Cigna CEO David Cordani said it âbuilds on Express Scriptsâ track record as the partner of choice and will present growth opportunities to provide additional Evernorth health services over time.â Added Chief Financial Officer Brian Evanko: âThis mutually beneficial partnership will bring significant revenue and be financially accretive over the course of the multi-year contract term.â In 2023, though, the new contract will create a âone-year headwindâ financially as Cignaâs Express Scripts division invests funds to get the new partnership started, executives acknowledged.Â
Read more© 2024 MMIT
The Latest
Meet Our Reporters
Meet Our Reporters
GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND
Sign up for publications to get unmatched business intelligence delivered to your inbox.